To the Editor-We read with interest the article by Broyles [1] describing a pre-post, retrospective cohort study at a 50-bed community hospital. Broyles [1] describes a comprehensive and resource-intensive intervention, including the development of an evidence-based procalcitonin algorithm (PCT-A) and numerous education sessions. Unique aspects of the study intervention include electronically building the PCT-A into the electronic medical record (EMR) and oversight by pharmacists, who were authorized to order PCT and adjust antibiotic regimens per protocol, resulting in 92% adherence to the PCT-A.
To emphasize the importance of developing a comprehensive intervention to aid in the success of PCT implementation, we describe our single-center experience, when adding the PCT assay (VIDAS B.R.A.H.M.S PCT) as an in-house test. Our institution is a 473-bed academic hospital with a well established antimicrobial stewardship program (ASP). Similar to Broyles' [1] study, an evidence-based PCT-A was developed, in which antibiotics were discouraged when PCT ≤0.25 ng/mL, and lectures were provided to physicians and pharmacists. Although guidance to help interpret PCT was provided in the comments section of the EMR, the full PCT-A was not built into the EMR, and a physiologic reference range of ≤0.09 ng/mL was inadvertently selected for use in the EMR based on the package insert [2] . Consequently, any value above 0.09 ng/mL flagged as elevated. Therefore, we aimed to evaluate the influence of laboratory reporting on the interpretation of PCT results and subsequent impact on antibiotic decision making.
We performed a retrospective cohort study of adult patients admitted from November 1, 2015 to October 31, 2016 with a first PCT concentration between 0.09 ng/mL and 0.25 ng/mL. We included 274 patients in our study with a median PCT concentration of 0.15 ng/mL. Most of the patients (47%) were suspected of having pneumonia or sepsis, but no suspected infection was documented in 29% of patients. Forty-three percent of patients had an elevated white blood cell count, 26% of patients had a T max > 101°F, and 38% of patients had neither sign of infection.
Procalcitonin interpretation was documented in 85 (31%) patients in progress notes. Among these patients, 61% of interpretations were inappropriate. An example of appropriate interpretation was "procalcitonin not suspicious for infection, " whereas an example of inappropriate interpretation was "infection ruled out, but will continue antibiotics because of elevated procalcitonin. " Patients with inappropriate interpretations received more antibiotics compared with patients with appropriate interpretations (7 versus 5 days, P = .05) despite having no differences in signs of infection and similar PCT values. In addition, antibiotics were more commonly initiated or broadened among patients with inappropriate interpretations (34% versus 9%, P < .01) ( Table 1) .
At our institution, implementation of PCT with a low reference range resulted in a high rate of inappropriate clinical interpretation and greater exposure to antibiotics, despite having a well established ASP, developing a PCT-A, and providing education. Our study has several limitations. First, the rate of PCT interpretations documented in the EMR was low. However, including only direct 
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